Session: Infection Prevention Surveillance and Data Collection in the ASC
The purpose of surveillance is to determine baseline rates, assess effectiveness of processes, identify where to concentrate efforts, and determine the need for further education.
COVID-19 & Antimicrobial Resistance
The U.S. lost progress combating antimicrobial resistance in 2020 due, in large part, to effects of the COVID-19 pandemic. The CDC COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022, concluded that the threat of antimicrobial-resistant infections is not only still present but has gotten worse.
APIC Calls on Healthcare Facilities to Assess Infection Prevention Workloads and Prioritize Critical Patient Safety Work
As Omicron Cases Continue to Surge, APIC Calls on Healthcare Facilities to Assess Infection Prevention Workloads and Prioritize Critical Patient Safety Work
Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2
A symptom-based strategy for determining when HCP with SARS-CoV-2 infection could return to work is preferred in most clinical situations.
Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease (COVID-19) Pandemic
CDC has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.
The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network
This report provides a national view of the increases in HAI incidence in 2020. These data highlight the need to return to conventional infection prevention and control practices and build resiliency in these programs to withstand future pandemics.
Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021
Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021
FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems
Throughout the pandemic, the FDA has worked closely with our federal partners at the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH), the Occupational Safety and Health Administration (OSHA) and with manufacturers to protect our front-line workers by facilitating access to the medical supplies they require. As a result of these efforts, our country is now better positioned to provide health care workers with access to NIOSH-approved N95s rather than using non-NIOSH-approved respirators or reusing decontaminated disposable respirators.
Clean Indoor Air Is Vital for Infection Control
In the aftermath of the COVID-19 pandemic, scientists say it's time to rate indoor air quality and clean it to prevent the spread of airborne illnesses.
Infections Associated with Urological Endoscopes
The U.S. Food and Drug Administration (FDA) wants to raise awareness among health care providers, including those working in reprocessing units in health care facilities, about the risk of infections associated with reprocessed urological endoscopes, including cystoscopes, ureteroscopes, and cystourethroscopes, used for viewing and accessing the urinary tract. The FDA has received numerous Medical Device Reports (MDRs) which describe patient infections post procedure or other possible contamination issues associated with reprocessing these devices.
As a nurse, having trustworthy, accurate information is vital during healthcare crises like COVID-19. These official CDC training materials are created by IPC experts for healthcare professionals. Learn PPE safety tips, infectious disease guidelines, how to speak to coworkers and patients about infection prevention, and more. Sign up today to learn how you can stop the spread.